LGD-3033 is primarily researched for its potential applications in the field of selective androgen receptor modulators (SARMs). It is being studied for its ability to promote muscle growth and enhance physical performance, making it a candidate for addressing muscle wasting diseases such as cachexia and sarcopenia. Additionally, it is explored for its potential in improving bone density, which could be beneficial in treating osteoporosis. Its selective action on androgen receptors in muscle and bone tissues, while minimizing effects on other organs, makes it a promising compound for therapeutic use in these areas. However, its application is still under investigation, and further research is needed to fully understand its efficacy and safety profile.